Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mark Cuban Cost Plus Drug Company is a public benefit corporation dedicated to providing affordable access to generic medications through a transparent pricing model. The company operates an online pharmacy that sells drugs at a fixed 15% markup over the manufacturer's cost, plus a flat $5 pharmacy service fee and a $5 shipping fee. By bypassing traditional pharmacy benefit managers and wholesalers, the company significantly reduces out-of-pocket costs for patients. In 2024, the company opened a 22,000-square-foot sterile fill-finish manufacturing facility in Dallas, Texas, to produce injectable drugs and address critical medication shortages. Their mission is to disrupt the pharmaceutical supply chain and ensure that no patient has to choose between their health and their financial stability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cost Plus.